Bumetanide and Solifenacin succinate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bumetanide and Solifenacin succinate. Common interactions include swelling face among females and atrial fibrillation among males.

The phase IV clinical study analyzes what interactions people who take Bumetanide and Solifenacin succinate have. It is created by eHealthMe based on reports of 11 people who take Bumetanide and Solifenacin succinate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On May, 26, 2023

11 people who take Bumetanide and Solifenacin succinate together, and have interactions are studied.


What is Bumetanide?

Bumetanide has active ingredients of bumetanide. It is often used in fluid retention. eHealthMe is studying from 17,320 Bumetanide users for its effectiveness, alternative drugs and more.

What is Solifenacin succinate?

Solifenacin succinate has active ingredients of solifenacin succinate. It is often used in urge incontinence. eHealthMe is studying from 1,444 Solifenacin succinate users for its effectiveness, alternative drugs and more.

Number of Bumetanide and Solifenacin succinate reports submitted per year:

Bumetanide and Solifenacin succinate drug interactions.

Common Bumetanide and Solifenacin Succinate drug interactions by gender *:

female:

  1. Swelling face
  2. Anaemia
  3. Arthropathy
  4. Atrial fibrillation
  5. Diabetes mellitus inadequate control
  6. Diarrhoea
  7. Drug ineffective
  8. Fall
  9. Haemorrhage intracranial
  10. Haemorrhagic stroke

male:

  1. Atrial fibrillation
  2. Constipation
  3. Lymphoedema
  4. Oxygen saturation decreased
  5. Pancytopenia
  6. Physical disability
  7. Depression
  8. Diarrhoea
  9. Dyspnoea
  10. Fall

Common Bumetanide and Solifenacin Succinate drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Local swelling
  2. Lymphoedema

60+:

  1. Swelling face
  2. Atrial fibrillation
  3. Dyspnoea
  4. Fatigue
  5. Haemorrhage intracranial
  6. Haemorrhagic stroke
  7. Hyponatraemia
  8. Hypotension
  9. Infusion related reaction
  10. Localised infection

Common conditions people have *:

  1. Urinary Tract Infection: 5 people, 45.45%
  2. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 18.18%
  3. Type 2 Diabetes: 2 people, 18.18%
  4. Weight Loss: 1 person, 9.09%
  5. High Blood Pressure: 1 person, 9.09%
  6. Back Pain: 1 person, 9.09%
  7. Constipation: 1 person, 9.09%
  8. Depression: 1 person, 9.09%
  9. Diabetes: 1 person, 9.09%
  10. Embolism (obstruction of an artery, typically by a clot of blood or an air bubble): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Bumetanide and Solifenacin succinate?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Bumetanide and Solifenacin succinate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Bumetanide side effects:

Browse all side effects of Bumetanide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Bumetanide interactions:

Browse all interactions between Bumetanide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Solifenacin succinate interactions:

Browse all interactions between Solifenacin succinate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on bumetanide and solifenacin succinate (the active ingredients of Bumetanide and Solifenacin succinate, respectively), and Bumetanide and Solifenacin succinate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Bumetanide and Solifenacin succinate.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: